Article
Embryological cellular origins and hypoxia-mediated mechanisms in PIK3CA-Driven refractory…
medRxiv · 2024 · Torii, S.; Nagaharu, K.; Nakanishi, N.; Usui, H.; Hori, Y.; Hirose, K.; Toyosawa, S.; Morii, E.; Narushima, M.; Kubota, Y.; Nakagawa, O.; Imanaka-Yoshida, K.; Maruyama, K.
Key facts
| Title | Embryological cellular origins and hypoxia-mediated mechanisms in PIK3CA-Driven refractory vascular malformations |
|---|---|
| First author | Torii, S.; Nagaharu, K.; Nakanishi, N.; Usui, H.; Hori, Y.; Hirose, K.; Toyosawa, S.; Morii, E.; Narushima, M.; Kubota, Y.; Nakagawa, O.; Imanaka-Yoshida, K.; Maruyama, K. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.10.16.618777 |
| Devices mentioned | K042884, K133972, K142003, K170858, K191495, K192440, K192932, K212956 |
| Product codes mentioned | IZH, IZL, MQB, MUE, MXZ, OWB, JAA, JJH, KPA, MYA, NJT, NKF and 2 more |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1